Medical Care

Global Sexually Transmitted Disease (STD) Diagnosis Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Disease (STD) Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Disease (STD) Diagnosis.
The Sexually Transmitted Disease (STD) Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sexually Transmitted Disease (STD) Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Disease (STD) Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMerieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Segment by Type
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Segment by Application
Government organizations
Hospitals
Diagnostic clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Disease (STD) Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chlamydia testing
1.2.3 Syphilis testing
1.2.4 Gonorrhoea testing
1.2.5 Herpes simplex virus testing
1.2.6 Human papilloma virus testing
1.2.7 Human immunodeficiency virus testing
1.3 Market by Application
1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2020-2031)
2.2 Global Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Region
2.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
2.3.1 Sexually Transmitted Disease (STD) Diagnosis Industry Trends
2.3.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers
2.3.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges
2.3.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue
3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
3.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
3.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2024
3.5 Global Key Players of Sexually Transmitted Disease (STD) Diagnosis Head office and Area Served
3.6 Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Product and Application
3.7 Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Type
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2026-2031)
5 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Application
5.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)
6.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)
6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)
7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)
7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)
9.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
11.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
11.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
11.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Aposcience
11.4.1 Aposcience Company Details
11.4.2 Aposcience Business Overview
11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
11.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.4.5 Aposcience Recent Development
11.5 BCR Diagnostics
11.5.1 BCR Diagnostics Company Details
11.5.2 BCR Diagnostics Business Overview
11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.5.5 BCR Diagnostics Recent Development
11.6 BD Medical
11.6.1 BD Medical Company Details
11.6.2 BD Medical Business Overview
11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
11.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.6.5 BD Medical Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Details
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
11.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.7.5 Biocartis Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Introduction
11.8.4 BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.8.5 BioMerieux Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
11.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
11.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.10.5 Cepheid Recent Development
11.11 Danaher
11.11.1 Danaher Company Details
11.11.2 Danaher Business Overview
11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
11.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.11.5 Danaher Recent Development
11.12 DiaSorin
11.12.1 DiaSorin Company Details
11.12.2 DiaSorin Business Overview
11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
11.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.12.5 DiaSorin Recent Development
11.13 Quidel
11.13.1 Quidel Company Details
11.13.2 Quidel Business Overview
11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
11.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.13.5 Quidel Recent Development
11.14 GenMark Diagnostics
11.14.1 GenMark Diagnostics Company Details
11.14.2 GenMark Diagnostics Business Overview
11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.14.5 GenMark Diagnostics Recent Development
11.15 Hologic
11.15.1 Hologic Company Details
11.15.2 Hologic Business Overview
11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
11.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.15.5 Hologic Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Details
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
11.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.16.5 OraSure Technologies Recent Development
11.17 Qualigen
11.17.1 Qualigen Company Details
11.17.2 Qualigen Business Overview
11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
11.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
11.17.5 Qualigen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chlamydia testing
Table 3. Key Players of Syphilis testing
Table 4. Key Players of Gonorrhoea testing
Table 5. Key Players of Herpes simplex virus testing
Table 6. Key Players of Human papilloma virus testing
Table 7. Key Players of Human immunodeficiency virus testing
Table 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2020-2025)
Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2026-2031)
Table 14. Sexually Transmitted Disease (STD) Diagnosis Market Trends
Table 15. Sexually Transmitted Disease (STD) Diagnosis Market Drivers
Table 16. Sexually Transmitted Disease (STD) Diagnosis Market Challenges
Table 17. Sexually Transmitted Disease (STD) Diagnosis Market Restraints
Table 18. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players (2020-2025)
Table 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2024)
Table 21. Ranking of Global Top Sexually Transmitted Disease (STD) Diagnosis Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Headquarters and Area Served
Table 24. Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Product and Application
Table 25. Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2020-2025)
Table 29. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2026-2031)
Table 31. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2020-2025)
Table 33. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2026-2031)
Table 35. North America Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 50. Abbott Company Details
Table 51. Abbott Business Overview
Table 52. Abbott Sexually Transmitted Disease (STD) Diagnosis Product
Table 53. Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Roche Company Details
Table 56. Roche Business Overview
Table 57. Roche Sexually Transmitted Disease (STD) Diagnosis Product
Table 58. Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 59. Roche Recent Development
Table 60. Thermo Fisher Scientific Company Details
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product
Table 63. Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Aposcience Company Details
Table 66. Aposcience Business Overview
Table 67. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product
Table 68. Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 69. Aposcience Recent Development
Table 70. BCR Diagnostics Company Details
Table 71. BCR Diagnostics Business Overview
Table 72. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
Table 73. BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 74. BCR Diagnostics Recent Development
Table 75. BD Medical Company Details
Table 76. BD Medical Business Overview
Table 77. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product
Table 78. BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 79. BD Medical Recent Development
Table 80. Biocartis Company Details
Table 81. Biocartis Business Overview
Table 82. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product
Table 83. Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 84. Biocartis Recent Development
Table 85. BioMerieux Company Details
Table 86. BioMerieux Business Overview
Table 87. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product
Table 88. BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 89. BioMerieux Recent Development
Table 90. Bio-Rad Company Details
Table 91. Bio-Rad Business Overview
Table 92. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product
Table 93. Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 94. Bio-Rad Recent Development
Table 95. Cepheid Company Details
Table 96. Cepheid Business Overview
Table 97. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product
Table 98. Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 99. Cepheid Recent Development
Table 100. Danaher Company Details
Table 101. Danaher Business Overview
Table 102. Danaher Sexually Transmitted Disease (STD) Diagnosis Product
Table 103. Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 104. Danaher Recent Development
Table 105. DiaSorin Company Details
Table 106. DiaSorin Business Overview
Table 107. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product
Table 108. DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 109. DiaSorin Recent Development
Table 110. Quidel Company Details
Table 111. Quidel Business Overview
Table 112. Quidel Sexually Transmitted Disease (STD) Diagnosis Product
Table 113. Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 114. Quidel Recent Development
Table 115. GenMark Diagnostics Company Details
Table 116. GenMark Diagnostics Business Overview
Table 117. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
Table 118. GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 119. GenMark Diagnostics Recent Development
Table 120. Hologic Company Details
Table 121. Hologic Business Overview
Table 122. Hologic Sexually Transmitted Disease (STD) Diagnosis Product
Table 123. Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 124. Hologic Recent Development
Table 125. OraSure Technologies Company Details
Table 126. OraSure Technologies Business Overview
Table 127. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product
Table 128. OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 129. OraSure Technologies Recent Development
Table 130. Qualigen Company Details
Table 131. Qualigen Business Overview
Table 132. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product
Table 133. Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)
Table 134. Qualigen Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Authors List of This Report


List of Figures
Figure 1. Sexually Transmitted Disease (STD) Diagnosis Picture
Figure 2. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Chlamydia testing Features
Figure 5. Syphilis testing Features
Figure 6. Gonorrhoea testing Features
Figure 7. Herpes simplex virus testing Features
Figure 8. Human papilloma virus testing Features
Figure 9. Human immunodeficiency virus testing Features
Figure 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2024 VS 2031
Figure 12. Government organizations Case Studies
Figure 13. Hospitals Case Studies
Figure 14. Diagnostic clinics Case Studies
Figure 15. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered
Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Sexually Transmitted Disease (STD) Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region: 2024 VS 2031
Figure 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players in 2024
Figure 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2024
Figure 22. North America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)
Figure 24. United States Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)
Figure 28. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2020-2031)
Figure 36. China Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)
Figure 44. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)
Figure 48. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abbott Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 54. Aposcience Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 55. BCR Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 56. BD Medical Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 57. Biocartis Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 58. BioMerieux Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 59. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 60. Cepheid Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 61. Danaher Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 62. DiaSorin Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 63. Quidel Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 64. GenMark Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 65. Hologic Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 66. OraSure Technologies Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 67. Qualigen Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies